Potential remdesivir-related transient bradycardia in patients with coronavirus disease 2019 (COVID-19)

J Med Virol. 2021 May;93(5):2631-2634. doi: 10.1002/jmv.26898. Epub 2021 Mar 3.
No abstract available

Publication types

  • Letter
  • Observational Study

MeSH terms

  • Adenosine Monophosphate / administration & dosage
  • Adenosine Monophosphate / adverse effects
  • Adenosine Monophosphate / analogs & derivatives*
  • Aged
  • Alanine / administration & dosage
  • Alanine / adverse effects
  • Alanine / analogs & derivatives*
  • Bradycardia / epidemiology
  • Bradycardia / etiology*
  • COVID-19 / epidemiology
  • COVID-19 Drug Treatment*
  • Female
  • Humans
  • Male
  • Middle Aged
  • Retrospective Studies
  • Risk Factors
  • SARS-CoV-2
  • Treatment Outcome

Substances

  • remdesivir
  • Adenosine Monophosphate
  • Alanine